Next Article in Journal
Achieving Smoke-Free Mental Health Services: Lessons from the Past Decade of Implementation Research
Next Article in Special Issue
Natural Exposure of Horses to Mosquito-Borne Flaviviruses in South-East Queensland, Australia
Previous Article in Journal
Gold Standard Program for Heavy Smokers in a Real-Life Setting
Previous Article in Special Issue
The Role of Australian Mosquito Species in the Transmission of Endemic and Exotic West Nile Virus Strains
Int. J. Environ. Res. Public Health 2013, 10(9), 4200-4223; doi:10.3390/ijerph10094200

A Review of Vaccine Approaches for West Nile Virus

†,*  and *
Division of Biotechnology and Molecular Medicine, Louisiana State University School of Veterinary Medicine, Skip Bertman Drive, Baton Rouge, LA 70803, USA Current Address: Boehringer Ingelheim Vetmedica, Suite 1000, Ames, IA 50010, USA.
* Authors to whom correspondence should be addressed.
Received: 8 July 2013 / Revised: 2 September 2013 / Accepted: 5 September 2013 / Published: 10 September 2013
(This article belongs to the Special Issue Epidemiology of West Nile Virus)
View Full-Text   |   Download PDF [275 KB, uploaded 19 June 2014]


The West Nile virus (WNC) first appeared in North America in 1999. The North American lineages of WNV were characterized by the presence of neuroinvasive and neurovirulent strains causing disease and death in humans, birds and horses. The 2012 WNV season in the United States saw a massive spike in the number of neuroinvasive cases and deaths similar to what was seen in the 2002–2003 season, according to the West Nile virus disease cases and deaths reported to the CDC by year and clinical presentation, 1999–2012, by ArboNET (Arboviral Diseases Branch, Centers for Disease Control and Prevention). In addition, the establishment and recent spread of lineage II WNV virus strains into Western Europe and the presence of neurovirulent and neuroinvasive strains among them is a cause of major concern. This review discusses the advances in the development of vaccines and biologicals to combat human and veterinary West Nile disease.
Keywords: West Nile Virus; vaccine; flaviviruses; envelope glycoprotein; WNV lineage; veterinary vaccine West Nile Virus; vaccine; flaviviruses; envelope glycoprotein; WNV lineage; veterinary vaccine
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Iyer, A.V.; Kousoulas, K.G. A Review of Vaccine Approaches for West Nile Virus. Int. J. Environ. Res. Public Health 2013, 10, 4200-4223.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert